Ira Jacobson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ira Jacobson

Showing results (41-50 of 46) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 46 results.

Gastroenterology|August 4, 2016

Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 TrialEric Lawitz, Nancy Reau, Federico Hinestrosa, et al.

World Journal of Gastroenterology|March 30, 2016

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1Ira Jacobson, Stefan Zeuzem, Robert Flisiak, et al.

Journal of Hepatology|December 24, 2013

Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null responseJohn M Vierling, Mitchell Davis, Steven Flamm, et al.

Gastrointestinal Endoscopy|February 28, 2002

"Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment of malignant biliary strictureMarc F Catalano, Joseph E Geenen, Glen A Lehman, et al.

The New England Journal of Medicine|January 17, 2014

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infectionMark S Sulkowski, David F Gardiner, Maribel Rodriguez-Torres, et al.

JAMA|May 6, 2015

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infectionFred Poordad, William Sievert, Lindsay Mollison, et al.

Pageof 5

Search research articles

Showing results (41-50 of 46) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 46 results.

Gastroenterology|August 4, 2016

Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 TrialEric Lawitz, Nancy Reau, Federico Hinestrosa, et al.

World Journal of Gastroenterology|March 30, 2016

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1Ira Jacobson, Stefan Zeuzem, Robert Flisiak, et al.

Journal of Hepatology|December 24, 2013

Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null responseJohn M Vierling, Mitchell Davis, Steven Flamm, et al.

Gastrointestinal Endoscopy|February 28, 2002

"Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment of malignant biliary strictureMarc F Catalano, Joseph E Geenen, Glen A Lehman, et al.

The New England Journal of Medicine|January 17, 2014

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infectionMark S Sulkowski, David F Gardiner, Maribel Rodriguez-Torres, et al.

JAMA|May 6, 2015

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infectionFred Poordad, William Sievert, Lindsay Mollison, et al.

Pageof 5